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DNA contains 174312 bp composed of 26 coding 
exons. 
Transcription 
3059 bp mRNA transcribed in centromeric to telomeric  
orientation; 2499 bp open reading frame. There are two 
isoforms of human ADAM23 (ADAM23alpha), i.e. 
ADAM23beta and ADAM23gamma. ADAM23beta is 
consistent with ADAM23alpha in domain structure 
except for a different transmembrane domain. 
ADAM23gamma, without transmembrane domain, is 
predicted to be a secreted form of ADAM23. 
ADAM23gamma is formed by skipping both exons 
enconding transmembrane domain in RNA splicing. 
Pseudogene 
No pseudogenes reported. 
 
 
DNA of ADAM23 gene composed of 26 coding exons. 
Protein 
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Description 
832amino acid protein including a hydrophobic 
transmembrane domain and eight potential N-linked 
glycosylation sites. This protein has multiple domain 
structures including a pro-, a metalloproteinase-lik , a 
desintegrin-like, a cysteine-rich, an epidermal growth 
factor-like, a transmembrane and a cytoplasmatic 
domain. Within the metalloproteinase-like domain, 
ADAM23 lacks HEXXHXXGXXH active-site amino 
acids for zinc-binding, which is critical for the 
proteinase activity. So, the metalloproteinase domain is 
inactive, suggesting that it is exclusively involved in 
cell adhesion processes rather than in protease-
mediated events. 
Expression 
Highly expressed in the brain and weakly expressed in 
the heart. In the brain, expressed prominently in the 
amygdala, caudate nucleus, hypothalamus, thalamus, 
cerebral cortex and occipital pole. 
Localisation 
Cell membrane; single-pass type I membrane protein 
(Potential). Isoform Gamma: Secreted protein. 
Function 
May play a role in cell-cell and cell-matrix interactions. 
This is a non-catalytic metalloprotease-like protein. 
Homology 







Note: There are one SNP on exon 1 in the amino acid 
position 1 with function start codon and two SNPs on 
exon 23 in the amino acid position 695 with functions 
synonymous and contig reference. 
Implicated in 
Gastric tumors 
Note: Hypermethylation of the promoter region of 
ADAM 23 gene, along with decreased expression, 
occurs in primary gastric tumors compared with 








Loss of ADAM23, which is likely to play an important 
role regard to cell-cell and cell- extracellular matrix 
interactions in gastric tissue as well, might be essential 
for the progression of gastric cancer. 
Breast tumors 
Note: Hypermethylation of the promoter region of 
ADAM23 gene, along with decreased expression, 
occurs in primary breast tumors and primary breast 







Primary breast tumors with a more advanced grade 
have a higher degree of methylation, suggesting that 
the adhesion molecule ADAM23 may be 
downregulated during the progression of breast cancer. 
Head and neck cancer 
Note: Hypermethylation of the promoter region of 
ADAM23 gene, along with decreased expression, 
occurs in Head and neck cancer and the frequency of 
hypermethylation of ADAM23 gene is higher in 







Hypermethylation of the ADAM23 gene could lead to 
tumor progression, because the neoplastic cells would 
lose the contact inhibition. As a consequence, these 
cells would proliferate in an uncontrolled manner; once 
the proliferation of most cancer cells is no longer 
sensitive to density-dependent inhibition, a permissive 
environment for cell proliferation is created. 
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